Cargando…
The clinical effects of cerebral near-infrared spectroscopy monitoring (NIRS) versus no monitoring: a protocol for a systematic review with meta-analysis and trial sequential analysis
BACKGROUND: Multiple clinical conditions are associated with cerebral hypoxia/ischaemia and thereby an increased risk of hypoxic-ischaemic brain injury. Cerebral near-infrared spectroscopy monitoring (NIRS) is a tool to monitor brain oxygenation and perfusion, and the clinical uptake of NIRS has exp...
Autores principales: | Hansen, Mathias Lühr, Hyttel-Sørensen, Simon, Jakobsen, Janus Christian, Gluud, Christian, Kooi, Elisabeth M. W., Mintzer, Jonathan, de Boode, Willem P., Fumagalli, Monica, Alarcon, Ana, Alderliesten, Thomas, Greisen, Gorm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052775/ https://www.ncbi.nlm.nih.gov/pubmed/33863369 http://dx.doi.org/10.1186/s13643-021-01660-2 |
Ejemplares similares
-
Central data monitoring in the multicentre randomised SafeBoosC-III trial – a pragmatic approach
por: Olsen, Markus Harboe, et al.
Publicado: (2021) -
Detailed statistical analysis plan for a secondary Bayesian analysis of the SafeBoosC-III trial: a multinational, randomised clinical trial assessing treatment guided by cerebral oximetry monitoring versus usual care in extremely preterm infants
por: Olsen, Markus Harboe, et al.
Publicado: (2023) -
Detailed statistical analysis plan for the SafeBoosC III trial: a multinational randomised clinical trial assessing treatment guided by cerebral oxygenation monitoring versus treatment as usual in extremely preterm infants
por: Hansen, Mathias Lühr, et al.
Publicado: (2019) -
Cerebral near-infrared spectroscopy monitoring versus treatment as usual for extremely preterm infants: a protocol for the SafeBoosC randomised clinical phase III trial
por: Hansen, Mathias Lühr, et al.
Publicado: (2019) -
Cerebral oximetry monitoring versus usual care for extremely preterm infants: a study protocol for the 2-year follow-up of the SafeBoosC-III randomised clinical trial
por: Rasmussen, Marie Isabel, et al.
Publicado: (2023)